RYTM- Rhythm Pharmaceuticals, Inc.
Rhythm Pharmaceuticals, Inc. (RYTM) has 15 insiders with recent SEC Form 4 filings, including 1 buy and 16 sells. RYTM is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 111.9K | $11.10M | - | |
| Other | 25.5K | $2.53M | - | |
| CEO | 14.1K | $1.40M | - | |
| Other | 8.4K | $830.4K | - | |
| Dir | 7.0K | $697.8K | - |
Activity
Buys and sells only
Transactions
10 filings · page 12
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 | Roberts William T. | Chief Accounting Officer | Sale+OE | 1,023 | $11.13 | $11,385.99 | -40.9% | -58.3% | +55.3% | |
| Feb 15, 2022 | Shulman Joseph | Chief Technical Officer | Sale+OE | 557 | $6.10 | $3,397.70 | -35.6% | -52.6% | +288.2% | |
| Feb 15, 2022 | Smith Hunter C | Chief Financial Officer | Sale+OE | 833 | $6.10 | $5,081.30 | -2.0% | -52.6% | +288.2% | |
| Feb 15, 2022 | Mazabraud Yann | EVP, Head Of International | Sale+OE | 934 | $6.10 | $5,697.40 | -46.0% | -52.6% | +288.2% | |
| Feb 15, 2022 | Chien Jennifer | EVP, Head Of North America | Sale+OE | 722 | $6.10 | $4,404.20 | -35.5% | -52.6% | +288.2% | |
| Mar 30, 2021 | Meeker David P | President And CEO | Buy | 10,000 | $20.17 | $201,713.00 | +9.9% | +1.5% | -44.2% | |
| Mar 15, 2021 | Foley Todd82 | Director | Sell | 1,000,000 | $25.10 | $25,100,000.00 | -52.4% | -21.3% | -63.0% | |
| Dec 3, 2020 | Ra Capital Management, L.P.53 | Former 10% Owner | Sell | 238,543 | $29.47 | $7,029,652.62 | -0.9% | - | - | |
| Aug 31, 2020 | Desikan Nithya | Chief Commercial Officer | Sale+OE | 25,000 | $30.00 | $750,000.00 | -36.4% | - | - | |
| Jul 2, 2020 | Ra Capital Management, L.P.53 | 10% Owner | Sell | 131,581 | $22.06 | $2,902,517.12 | -0.8% | - | - |